IDEAS home Printed from
   My bibliography  Save this paper

Hälsoekonomiska utvärderingar som underlag för beslut om pris och subventionering. Riktlinjer och beslutskriterier


  • Jönsson, Bengt

    () (Dept. of Economics, Stockholm School of Economics)

  • Lundkvist, Jonas

    () (Dept. of Economics, Stockholm School of Economics)


Intresse och användning av hälsoekonomiska utvärderingar som underlag vid beslut om pris och subentionering av läkemedel ökar i de flesta länder. Många länder har infört mer eller mindre formella krav på hälsoekonomisk dokumentation inför sådana beslut och ett flertal länder och organisationer har även tagit fram riktlinjer för hur ekonomiska utvärderingar bör vara utförda. En genomgång av dessa riktlinjer visar att det finns stora likheter mellan dem, även om det finns skillnader i vissa detaljer. Ekonomiska utvärderingar bildar i allt ökande utsträckning underlag för beslut, men det är dock oklart vilken roll de i praktiken spelar.

Suggested Citation

  • Jönsson, Bengt & Lundkvist, Jonas, 2002. "Hälsoekonomiska utvärderingar som underlag för beslut om pris och subventionering. Riktlinjer och beslutskriterier," SSE/EFI Working Paper Series in Economics and Finance 504, Stockholm School of Economics, revised 28 Aug 2002.
  • Handle: RePEc:hhs:hastef:0504

    Download full text from publisher

    File URL:
    Download Restriction: no

    References listed on IDEAS

    1. Meltzer, David, 1997. "Accounting for future costs in medical cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 16(1), pages 33-64, February.
    2. David Meltzer, 1997. "Accounting for Future Costs in Medical Cost-Effectiveness Analysis," NBER Working Papers 5946, National Bureau of Economic Research, Inc.
    Full references (including those not matched with items on IDEAS)

    More about this item


    Läkemedel; riktlinjer; ekonomiska utvärderingar; subventionering; prissättning.;

    JEL classification:

    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    NEP fields

    This paper has been announced in the following NEP Reports:


    Access and download statistics


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hhs:hastef:0504. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Helena Lundin). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.